1. Novel antitumor indolocarbazole compound 6-N-formylamino-12, 13-dihydro-1,11 -dihydroxy-13-(β-D-glucopyranosyl)-5H-indolo-[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506): induction of topoisomerase I-mediated DNA cleavage and mechanisms of cell line-selective cytotoxicity;Yoshinari;Cancer Res.,1995
2. Novel indolocarbazole compound 6-N-formylamino-2,13-dihydro-1,11-dihydroxy-13-(β-D-glucopyranosyl)-5H-indolo[2,3-a]pyrrole-[3,4-c]carbazole-5,7(6H)-dione (NB-506): its potent antitumor activity in mice;Arakawa;Cancer Res.,1995
3. Mode of action of a new indolocarbazole anticancer agent, J-107088, targeting topoisomerase I;Yoshinari;Cancer Res.,1999
4. Antimetastatic effect of a novel indolocarbazole (NB-506) on IMC-HM murine tumor cells metastasized to the liver;Arakawa;Jpn. J. Cancer Res.,1996
5. Practical synthesis of indolopyrrolocarbazoles;Ohkubo;Tetrahedron,1996